118 related articles for article (PubMed ID: 38904213)
1. Long-Term Improvements in Glycemic Control with Dexcom CGM Use in Adults with Noninsulin-Treated Type 2 Diabetes.
Layne JE; Jepson LH; Carite AM; Parkin CG; Bergenstal RM
Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38904213
[No Abstract] [Full Text] [Related]
2. Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes.
Dunn TC; Ajjan RA; Bergenstal RM; Xu Y
Diabetes Technol Ther; 2024 Mar; 26(3):203-210. PubMed ID: 38444315
[TBL] [Abstract][Full Text] [Related]
3. Glycemic Outcomes and Feature Set Engagement Among Real-Time Continuous Glucose Monitoring Users With Type 1 or Non-Insulin-Treated Type 2 Diabetes: Retrospective Analysis of Real-World Data.
Dowd R; Jepson LH; Green CR; Norman GJ; Thomas R; Leone K
JMIR Diabetes; 2023 Jan; 8():e43991. PubMed ID: 36602920
[TBL] [Abstract][Full Text] [Related]
4. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
[No Abstract] [Full Text] [Related]
5. Impact of a Combined Continuous Glucose Monitoring-Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study.
Kumbara AB; Iyer AK; Green CR; Jepson LH; Leone K; Layne JE; Shomali M
JMIR Diabetes; 2023 Sep; 8():e47638. PubMed ID: 37590491
[TBL] [Abstract][Full Text] [Related]
6. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70-180 mg/dL Versus Time-in-Tight-Range 70-140 mg/dL.
Beck RW; Raghinaru D; Calhoun P; Bergenstal RM
Diabetes Technol Ther; 2024 Mar; 26(3):151-155. PubMed ID: 37870460
[No Abstract] [Full Text] [Related]
8. Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT-CGM system in Germany, Sweden and the United Kingdom (2018-2020).
Acciaroli G; van der Linden J; Chao C; Walker TC; Oliver N
Diabet Med; 2023 Feb; 40(2):e14946. PubMed ID: 36053809
[TBL] [Abstract][Full Text] [Related]
9. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial.
Majithia AR; Kusiak CM; Armento Lee A; Colangelo FR; Romanelli RJ; Robertson S; Miller DP; Erani DM; Layne JE; Dixon RF; Zisser H
J Med Internet Res; 2020 Aug; 22(8):e21778. PubMed ID: 32856597
[TBL] [Abstract][Full Text] [Related]
10. Time in Range, Time in Tight Range, and Average Glucose Relationships Are Modulated by Glycemic Variability: Identification of a Glucose Distribution Model Connecting Glycemic Parameters Using Real-World Data.
Xu Y; Dunn TC; Bergenstal RM; Cheng A; Dabiri Y; Ajjan RA
Diabetes Technol Ther; 2024 Feb; ():. PubMed ID: 38315505
[No Abstract] [Full Text] [Related]
11. Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis.
Galindo RJ; Moazzami B; Tuttle KR; Bergenstal RM; Peng L; Umpierrez GE
Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38805310
[No Abstract] [Full Text] [Related]
12. The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes.
Idrees T; Zabala ZE; Moreno EM; Gerges A; Urrutia MA; Ruiz JG; Vaughan C; Vellanki P; Pasquel FJ; Peng L; Umpierrez GE
Diabetes Res Clin Pract; 2023 Apr; 198():110603. PubMed ID: 36871877
[TBL] [Abstract][Full Text] [Related]
13. Continuous Glucose Monitoring-Guided Insulin Administration in Long-Term Care Facilities: A Randomized Clinical Trial.
Idrees T; Castro-Revoredo IA; Oh HD; Gavaller MD; Zabala Z; Moreno E; Moazzami B; Galindo RJ; Vellanki P; Cabb E; Johnson TM; Peng L; Umpierrez GE
J Am Med Dir Assoc; 2024 May; 25(5):884-888. PubMed ID: 38460943
[TBL] [Abstract][Full Text] [Related]
14. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
15. Real-World Evidence and Glycemic Improvement Using Dexcom G6 Features.
Akturk HK; Dowd R; Shankar K; Derdzinski M
Diabetes Technol Ther; 2021 Mar; 23(S1):S21-S26. PubMed ID: 33434439
[No Abstract] [Full Text] [Related]
16. Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a New Continuous Glucose Monitoring Metric in Children and Adolescents with Type 1 Diabetes Using Different Treatment Modalities.
Passanisi S; Piona C; Salzano G; Marigliano M; Bombaci B; Morandi A; Alibrandi A; Maffeis C; Lombardo F
Diabetes Technol Ther; 2024 Mar; 26(3):161-166. PubMed ID: 37902743
[No Abstract] [Full Text] [Related]
17. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.
Brener A; Mazor-Aronovitch K; Rachmiel M; Levek N; Barash G; Pinhas-Hamiel O; Lebenthal Y; Landau Z
Acta Diabetol; 2020 Dec; 57(12):1511-1517. PubMed ID: 33026497
[TBL] [Abstract][Full Text] [Related]
18. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
Martens T; Beck RW; Bailey R; Ruedy KJ; Calhoun P; Peters AL; Pop-Busui R; Philis-Tsimikas A; Bao S; Umpierrez G; Davis G; Kruger D; Bhargava A; Young L; McGill JB; Aleppo G; Nguyen QT; Orozco I; Biggs W; Lucas KJ; Polonsky WH; Buse JB; Price D; Bergenstal RM;
JAMA; 2021 Jun; 325(22):2262-2272. PubMed ID: 34077499
[TBL] [Abstract][Full Text] [Related]
19. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
20. G6 continuous glucose monitoring system feature use and its associations with glycaemia in Europe.
Acciaroli G; Parkin CG; Thomas R; Layne J; Norman GJ; Leone K
Diabet Med; 2023 Jun; 40(6):e15093. PubMed ID: 36951684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
